Yukihiko Iizuka
About Yukihiko Iizuka
Yukihiko Iizuka is an Associate Director at Insmed Incorporated, with extensive experience in medical strategy and data generation across various fields, including neuroscience and regenerative medicine. He has held multiple roles in academia and the pharmaceutical industry, contributing to medical affairs and project management.
Current Role at Insmed
Yukihiko Iizuka serves as Associate Director at Insmed Incorporated, a position he has held since 2022. In this role, he focuses on medical strategy and data generation, contributing to the company's initiatives in the pharmaceutical sector. His expertise in neuroscience, regenerative medicine, and immuno-oncology supports Insmed's objectives in advancing medical treatments.
Previous Experience in Academia
Yukihiko Iizuka has a background in academia, having worked as an Assistant Professor at 慶應義塾大学 for one year from 2003 to 2004. He also served as a Research Fellow at the National Institute of Mental Health (NIMH) from 2004 to 2009 for five years, where he engaged in research activities that contributed to his expertise in medical fields.
Professional Background in Medical Affairs
Iizuka has extensive experience in medical affairs, having held various positions in the pharmaceutical industry. He worked as a Senior Manager in Medical Affairs at SanBio, Inc. from 2021 to 2022 and as Medical Lead at UCB from 2019 to 2020. His role at Novartis as Medical Scientific Expert from 2013 to 2016 further solidified his expertise in medical strategy and project management.
Education and Expertise
Yukihiko Iizuka holds a Bachelor of Science degree in Biotechnology from 創価大学, which he completed from 1993 to 1997. He further pursued a Ph.D. in Medicine at 慶應義塾大学 from 1997 to 2003. His educational background laid the foundation for his expertise in medical strategy, data generation, and geriatric medicine.
Research Fellowships and Contributions
Iizuka's early career included significant research fellowships. He worked as a Research Fellow (DC2) at 日本学術振興会 from 2001 to 2003 and later at 名古屋大学 from 2009 to 2013. These positions allowed him to contribute to various medical research projects, enhancing his knowledge in neuroscience and regenerative medicine.